Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Awada

Showing results (301-310 of 311) with videos related to

Pageof 32
Sort By:
Breast Cancer Research and Treatment|June 27, 2007
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative studyPatrick Neven, Robert Paridaens, Gino Pelgrims, et al.
ESMO Open|August 28, 2020
Oncological care organisation during COVID-19 outbreakConcetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
Biomedicines|July 2, 2021
The NHance<sup>®</sup> Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer PatientsPhilippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
JCO Global Oncology|September 8, 2020
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to ArmsKamal S Saini, Begoña de Las Heras, Ruth Plummer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid TumorsTae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Cancers|September 10, 2021
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Mario Giuliano, Matteo Lambertini, et al.
Cancer Treatment Reviews|October 6, 2022
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancerFrancesco Schettini, Sergio Venturini, Mario Giuliano, et al.
The Lancet. Oncology|April 1, 2020
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trialJosé Trigo, Vivek Subbiah, Benjamin Besse, et al.
Lung Cancer (Amsterdam, Netherlands)|October 23, 2020
Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatmentVivek Subbiah, Luis Paz-Ares, Benjamin Besse, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumoursRobin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Pageof 32

Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Breast Cancer Research and Treatment|June 27, 2007
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative studyPatrick Neven, Robert Paridaens, Gino Pelgrims, et al.
ESMO Open|August 28, 2020
Oncological care organisation during COVID-19 outbreakConcetta Elisa Onesti, Hope S Rugo, Daniele Generali, et al.
Biomedicines|July 2, 2021
The NHance<sup>®</sup> Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer PatientsPhilippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
JCO Global Oncology|September 8, 2020
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to ArmsKamal S Saini, Begoña de Las Heras, Ruth Plummer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid TumorsTae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Cancers|September 10, 2021
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast CancerFrancesco Schettini, Mario Giuliano, Matteo Lambertini, et al.
Cancer Treatment Reviews|October 6, 2022
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancerFrancesco Schettini, Sergio Venturini, Mario Giuliano, et al.
The Lancet. Oncology|April 1, 2020
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trialJosé Trigo, Vivek Subbiah, Benjamin Besse, et al.
Lung Cancer (Amsterdam, Netherlands)|October 23, 2020
Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatmentVivek Subbiah, Luis Paz-Ares, Benjamin Besse, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumoursRobin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Pageof 32